United States mAb Biosimilar Market Report 2016

United States mAb Biosimilar Market Report 2016

1 mAb Biosimilar Overview

1.1 Product Overview and Scope of mAb Biosimilar

1.2 Classification of mAb Biosimilar

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of mAb Biosimilar

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of mAb Biosimilar (2011-2021)

1.4.1 United States mAb Biosimilar Sales and Growth Rate (2011-2021)

1.4.2 United States mAb Biosimilar Revenue and Growth Rate (2011-2021)

2 United States mAb Biosimilar Competition by Manufacturers

2.1 United States mAb Biosimilar Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States mAb Biosimilar Revenue and Share by Manufactures (2015 and 2016)

2.3 United States mAb Biosimilar Average Price by Manufactures (2015 and 2016)

2.4 mAb Biosimilar Market Competitive Situation and Trends

2.4.1 mAb Biosimilar Market Concentration Rate

2.4.2 mAb Biosimilar Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States mAb Biosimilar Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States mAb Biosimilar Sales and Market Share by Type (2011-2016)

3.2 United States mAb Biosimilar Revenue and Market Share by Type (2011-2016)

3.3 United States mAb Biosimilar Price by Type (2011-2016)

3.4 United States mAb Biosimilar Sales Growth Rate by Type (2011-2016)

4 United States mAb Biosimilar Sales (Volume) by Application (2011-2016)

4.1 United States mAb Biosimilar Sales and Market Share by Application (2011-2016)

4.2 United States mAb Biosimilar Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States mAb Biosimilar Manufacturers Profiles/Analysis

5.1 Baxter

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 mAb Biosimilar Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Baxter mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 GSK

5.2.2 mAb Biosimilar Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 GSK mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Merck

5.3.2 mAb Biosimilar Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Merck mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Novartis

5.4.2 mAb Biosimilar Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Novartis mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Pfizer

5.5.2 mAb Biosimilar Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Pfizer mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Roche Holding

5.6.2 mAb Biosimilar Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Roche Holding mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Sanofi

5.7.2 mAb Biosimilar Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Sanofi mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Mitsubishi Tanabe Pharma

5.8.2 mAb Biosimilar Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Mitsubishi Tanabe Pharma mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Hospira

5.9.2 mAb Biosimilar Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Hospira mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Alvartis Pharma

5.10.2 mAb Biosimilar Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Alvartis Pharma mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Allergan

5.12 Amega Biotech

5.13 Biogen

5.14 LG Lifesciences

5.15 Samsung Biologics

6 mAb Biosimilar Manufacturing Cost Analysis

6.1 mAb Biosimilar Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of mAb Biosimilar

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 mAb Biosimilar Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of mAb Biosimilar Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States mAb Biosimilar Market Forecast (2016-2021)

10.1 United States mAb Biosimilar Sales, Revenue Forecast (2016-2021)

10.2 United States mAb Biosimilar Sales Forecast by Type (2016-2021)

10.3 United States mAb Biosimilar Sales Forecast by Application (2016-2021)

10.4 mAb Biosimilar Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of mAb Biosimilar

Table Classification of mAb Biosimilar

Figure United States Sales Market Share of mAb Biosimilar by Type in 2015

Table Application of mAb Biosimilar

Figure United States Sales Market Share of mAb Biosimilar by Application in 2015

Figure United States mAb Biosimilar Sales and Growth Rate (2011-2021)

Figure United States mAb Biosimilar Revenue and Growth Rate (2011-2021)

Table United States mAb Biosimilar Sales of Key Manufacturers (2015 and 2016)

Table United States mAb Biosimilar Sales Share by Manufacturers (2015 and 2016)

Figure 2015 mAb Biosimilar Sales Share by Manufacturers

Figure 2016 mAb Biosimilar Sales Share by Manufacturers

Table United States mAb Biosimilar Revenue by Manufacturers (2015 and 2016)

Table United States mAb Biosimilar Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States mAb Biosimilar Revenue Share by Manufacturers

Table 2016 United States mAb Biosimilar Revenue Share by Manufacturers

Table United States Market mAb Biosimilar Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market mAb Biosimilar Average Price of Key Manufacturers in 2015

Figure mAb Biosimilar Market Share of Top 3 Manufacturers

Figure mAb Biosimilar Market Share of Top 5 Manufacturers

Table United States mAb Biosimilar Sales by Type (2011-2016)

Table United States mAb Biosimilar Sales Share by Type (2011-2016)

Figure United States mAb Biosimilar Sales Market Share by Type in 2015

Table United States mAb Biosimilar Revenue and Market Share by Type (2011-2016)

Table United States mAb Biosimilar Revenue Share by Type (2011-2016)

Figure Revenue Market Share of mAb Biosimilar by Type (2011-2016)

Table United States mAb Biosimilar Price by Type (2011-2016)

Figure United States mAb Biosimilar Sales Growth Rate by Type (2011-2016)

Table United States mAb Biosimilar Sales by Application (2011-2016)

Table United States mAb Biosimilar Sales Market Share by Application (2011-2016)

Figure United States mAb Biosimilar Sales Market Share by Application in 2015

Table United States mAb Biosimilar Sales Growth Rate by Application (2011-2016)

Figure United States mAb Biosimilar Sales Growth Rate by Application (2011-2016)

Table Baxter Basic Information List

Table Baxter mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Baxter mAb Biosimilar Sales Market Share (2011-2016)

Table GSK Basic Information List

Table GSK mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table GSK mAb Biosimilar Sales Market Share (2011-2016)

Table Merck Basic Information List

Table Merck mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck mAb Biosimilar Sales Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis mAb Biosimilar Sales Market Share (2011-2016)

Table Pfizer Basic Information List

Table Pfizer mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer mAb Biosimilar Sales Market Share (2011-2016)

Table Roche Holding Basic Information List

Table Roche Holding mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Roche Holding mAb Biosimilar Sales Market Share (2011-2016)

Table Sanofi Basic Information List

Table Sanofi mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi mAb Biosimilar Sales Market Share (2011-2016)

Table Mitsubishi Tanabe Pharma Basic Information List

Table Mitsubishi Tanabe Pharma mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Mitsubishi Tanabe Pharma mAb Biosimilar Sales Market Share (2011-2016)

Table Hospira Basic Information List

Table Hospira mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Hospira mAb Biosimilar Sales Market Share (2011-2016)

Table Alvartis Pharma Basic Information List

Table Alvartis Pharma mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Alvartis Pharma mAb Biosimilar Sales Market Share (2011-2016)

Table Allergan Basic Information List

Table Allergan mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Allergan mAb Biosimilar Sales Market Share (2011-2016)

Table Amega Biotech Basic Information List

Table Amega Biotech mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Amega Biotech mAb Biosimilar Sales Market Share (2011-2016)

Table Biogen Basic Information List

Table Biogen mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Biogen mAb Biosimilar Sales Market Share (2011-2016)

Table LG Lifesciences Basic Information List

Table LG Lifesciences mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table LG Lifesciences mAb Biosimilar Sales Market Share (2011-2016)

Table Samsung Biologics Basic Information List

Table Samsung Biologics mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Samsung Biologics mAb Biosimilar Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of mAb Biosimilar

Figure Manufacturing Process Analysis of mAb Biosimilar

Figure mAb Biosimilar Industrial Chain Analysis

Table Raw Materials Sources of mAb Biosimilar Major Manufacturers in 2015

Table Major Buyers of mAb Biosimilar

Table Distributors/Traders List

Figure United States mAb Biosimilar Production and Growth Rate Forecast (2016-2021)

Figure United States mAb Biosimilar Revenue and Growth Rate Forecast (2016-2021)

Table United States mAb Biosimilar Production Forecast by Type (2016-2021)

Table United States mAb Biosimilar Consumption Forecast by Application (2016-2021)